Key result
The Arg213->Gly mutation in extracellular superoxide dismutase reduces both heparin and collagen affinities by approximately 12-fold compared to the wild-type enzyme.
Answers are grounded in this paper and cite their sources.
The R213G mutation in EC-SOD reduces its affinity for both heparin and collagen, providing a biochemical mechanism for the increased plasma concentration of the enzyme and potentially explaining the increased cardiovascular risk in carriers due to reduced tissue antioxidant protection.
The C-terminal region of EC-SOD (extracellular superoxide dismutase) mediates the binding to both heparin/heparan sulphate and type I collagen. A mutation (Arg213-->Gly; R213G) within this extracellular matrix-binding region has recently been implicated in the development of heart disease. This relatively common mutation affects the heparin affinity, and the concentration of EC-SOD in the plasma of R213G homozygous individuals is increased 10- to 30-fold. In the present study we confirm, using R213G EC-SOD purified from a homozygous individual, that the heparin affinity is reduced. Significantly, the collagen affinity of the R213G EC-SOD variant was similarly affected and both the heparin and collagen affinities were reduced by 12-fold. Structural analysis of synthetic extracellular matrix-binding regions suggests that the mutation alters the secondary structure. We conclude that the increased concentration of EC-SOD in the plasma of R213G carriers is caused by a reduction in both heparin and collagen affinities.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (2005) studied Arg213->Gly mutation in EC-SOD. Arg213->Gly (R213G) mutation vs. Wild-type EC-SOD was evaluated on Heparin and collagen affinity (12-fold reduction). The Arg213->Gly mutation in extracellular superoxide dismutase reduces both heparin and collagen affinities by approximately 12-fold compared to the wild-type enzyme.
Synapse has enriched 10 related papers. Consider them for comparative context: